Actinium-225, The Joint-Venture Pantera To Secure Its Production The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announced last week the name of their joint-venture: Pantera SA/NV, resulting from strategic R&D partnership between SCK CEN and IBA to enable the production…
SCK CEN and IRE Ready To Start Lutetium-177 Large-Scale Production SCK CEN (ENS Corporate Member) and the National Institute for Radioelements (IRE) are going to start the large-scale production of lutetium-177. This decision opens up opportunities for cancer patients. Lutetium-177 is currently used in hospitals to treat neuroendocrine tumours. Neuroendocrine cells are found primarily in the…
BR2’s Radioisotopes Helped More Than 10 Millions Patients in 2021 In 2021, more than 10 million patients were helped thanks to the production of medical radioisotopes in the Belgian research reactor BR2, as reported the Belgian nuclear research centre SCK CEN (ENS Corporate Member). At each operating cycle, it provides the necessary raw materials used…
MYRRHA Project Achieves an Important Development Milestone The MYRRHA project has achieved a development milestone after researchers at the Belgian Nuclear Research Centre (SCK•CEN) succeeded for the first time in accelerating a proton beam through the recently connected radio frequency quadrupole (RFQ). The RFQ is a component of the particle accelerator that will drive the…
SCK CEN helped increasing COVID-19 testing capacity in Belgium On 30 March 2020, the Belgian Nuclear Research Centre (SCK CEN) handed over a qPCR equipment to the Belgian Task Force. In that way, SCK CEN contributed to the national effort to increase testing capacity in Belgium from 2,000 to 10,000 tests per day. At the…